Logo image of DOC

HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis

NYSE:DOC - New York Stock Exchange, Inc. - US42250P1030 - REIT - Currency: USD

19.9476  -0.26 (-1.3%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DOC. DOC was compared to 128 industry peers in the Diversified REITs industry. While DOC is still in line with the averages on profitability rating, there are concerns on its financial health. DOC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year DOC was profitable.
In the past year DOC had a positive cash flow from operations.
In the past 5 years DOC has always been profitable.
In the past 5 years DOC always reported a positive cash flow from operatings.
DOC Yearly Net Income VS EBIT VS OCF VS FCFDOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

DOC's Return On Assets of 1.22% is in line compared to the rest of the industry. DOC outperforms 58.40% of its industry peers.
DOC has a Return On Equity of 2.89%. This is comparable to the rest of the industry: DOC outperforms 56.80% of its industry peers.
With a Return On Invested Capital value of 2.63%, DOC perfoms like the industry average, outperforming 50.40% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.13%.
The last Return On Invested Capital (2.63%) for DOC is above the 3 year average (2.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.22%
ROE 2.89%
ROIC 2.63%
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.39%
ROIC(5y)2.05%
DOC Yearly ROA, ROE, ROICDOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

DOC has a Profit Margin of 8.98%. This is comparable to the rest of the industry: DOC outperforms 57.60% of its industry peers.
DOC's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 21.71%, DOC perfoms like the industry average, outperforming 50.40% of the companies in the same industry.
DOC's Operating Margin has declined in the last couple of years.
DOC's Gross Margin of 64.46% is on the low side compared to the rest of the industry. DOC is outperformed by 63.20% of its industry peers.
DOC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.71%
PM (TTM) 8.98%
GM 64.46%
OM growth 3Y5.47%
OM growth 5Y-2.9%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y2.83%
GM growth 5Y-0.77%
DOC Yearly Profit, Operating, Gross MarginsDOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

2

2. Health

2.1 Basic Checks

DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, DOC has more shares outstanding
DOC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DOC has about the same debt to assets ratio.
DOC Yearly Shares OutstandingDOC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
DOC Yearly Total Debt VS Total AssetsDOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

DOC has an Altman-Z score of 0.48. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.48, DOC perfoms like the industry average, outperforming 43.20% of the companies in the same industry.
The Debt to FCF ratio of DOC is 18.70, which is on the high side as it means it would take DOC, 18.70 years of fcf income to pay off all of its debts.
DOC has a Debt to FCF ratio of 18.70. This is in the better half of the industry: DOC outperforms 76.00% of its industry peers.
A Debt/Equity ratio of 0.94 indicates that DOC is somewhat dependend on debt financing.
DOC has a better Debt to Equity ratio (0.94) than 60.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 18.7
Altman-Z 0.48
ROIC/WACC0.39
WACC6.73%
DOC Yearly LT Debt VS Equity VS FCFDOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.08 indicates that DOC may have some problems paying its short term obligations.
The Current ratio of DOC (0.08) is worse than 99.20% of its industry peers.
DOC has a Quick Ratio of 0.08. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.08, DOC is not doing good in the industry: 99.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
DOC Yearly Current Assets VS Current LiabilitesDOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

DOC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.50%.
DOC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.64% yearly.
The Revenue has grown by 23.82% in the past year. This is a very strong growth!
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.84% yearly.
EPS 1Y (TTM)-37.5%
EPS 3Y-2.7%
EPS 5Y-2.64%
EPS Q2Q%-92.31%
Revenue 1Y (TTM)23.82%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%26.07%

3.2 Future

Based on estimates for the next years, DOC will show a decrease in Earnings Per Share. The EPS will decrease by -2.84% on average per year.
Based on estimates for the next years, DOC will show a very negative growth in Revenue. The Revenue will decrease by -29.18% on average per year.
EPS Next Y-36.83%
EPS Next 2Y-10.92%
EPS Next 3Y-9.72%
EPS Next 5Y-2.84%
Revenue Next Year5.01%
Revenue Next 2Y4.57%
Revenue Next 3Y4.61%
Revenue Next 5Y-29.18%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DOC Yearly Revenue VS EstimatesDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
DOC Yearly EPS VS EstimatesDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 56.99, the valuation of DOC can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of DOC is on the same level as its industry peers.
DOC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.43.
A Price/Forward Earnings ratio of 90.23 indicates a quite expensive valuation of DOC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DOC is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, DOC is valued quite expensively.
Industry RankSector Rank
PE 56.99
Fwd PE 90.23
DOC Price Earnings VS Forward Price EarningsDOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

DOC's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOC indicates a somewhat cheap valuation: DOC is cheaper than 65.60% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 29.93
EV/EBITDA 13.83
DOC Per share dataDOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as DOC's earnings are expected to decrease with -9.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.92%
EPS Next 3Y-9.72%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.17%, DOC is a good candidate for dividend investing.
DOC's Dividend Yield is a higher than the industry average which is at 18.33.
DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 6.17%

5.2 History

The dividend of DOC decreases each year by -2.76%.
DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
DOC Yearly Dividends per shareDOC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DOC pays out 327.90% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of DOC has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP327.9%
EPS Next 2Y-10.92%
EPS Next 3Y-9.72%
DOC Yearly Income VS Free CF VS DividendDOC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B
DOC Dividend Payout.DOC Dividend Payout, showing the Payout Ratio.DOC Dividend Payout.PayoutRetained Earnings

HEALTHPEAK PROPERTIES INC

NYSE:DOC (2/26/2025, 3:13:48 PM)

19.9476

-0.26 (-1.3%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners94.75%
Inst Owner Change-100%
Ins Owners0.28%
Ins Owner Change-1.85%
Market Cap13.95B
Analysts80.83
Price Target25.16 (26.13%)
Short Float %1.76%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield 6.17%
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP327.9%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-14 2025-02-14 (0.305)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.57%
Min EPS beat(2)-79.16%
Max EPS beat(2)76.02%
EPS beat(4)2
Avg EPS beat(4)10.32%
Min EPS beat(4)-86.62%
Max EPS beat(4)131.02%
EPS beat(8)5
Avg EPS beat(8)31.06%
EPS beat(12)8
Avg EPS beat(12)58.38%
EPS beat(16)9
Avg EPS beat(16)40.26%
Revenue beat(2)2
Avg Revenue beat(2)1.14%
Min Revenue beat(2)0.34%
Max Revenue beat(2)1.94%
Revenue beat(4)4
Avg Revenue beat(4)3.28%
Min Revenue beat(4)0.34%
Max Revenue beat(4)7.87%
Revenue beat(8)6
Avg Revenue beat(8)-7.44%
Revenue beat(12)8
Avg Revenue beat(12)-4.82%
Revenue beat(16)12
Avg Revenue beat(16)35.62%
PT rev (1m)-2.37%
PT rev (3m)-3.01%
EPS NQ rev (1m)-0.63%
EPS NQ rev (3m)-55.07%
EPS NY rev (1m)0.51%
EPS NY rev (3m)-13.97%
Revenue NQ rev (1m)-1.63%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE 56.99
Fwd PE 90.23
P/S 5.17
P/FCF 29.93
P/OCF 13.04
P/B 1.66
P/tB 1.84
EV/EBITDA 13.83
EPS(TTM)0.35
EY1.75%
EPS(NY)0.22
Fwd EY1.11%
FCF(TTM)0.67
FCFY3.34%
OCF(TTM)1.53
OCFY7.67%
SpS3.86
BVpS12.01
TBVpS10.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.22%
ROE 2.89%
ROCE 3.33%
ROIC 2.63%
ROICexc 2.65%
ROICexgc 2.94%
OM 21.71%
PM (TTM) 8.98%
GM 64.46%
FCFM 17.26%
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.39%
ROIC(5y)2.05%
ROICexc(3y)2.4%
ROICexc(5y)2.06%
ROICexgc(3y)2.61%
ROICexgc(5y)2.23%
ROCE(3y)3.02%
ROCE(5y)2.59%
ROICexcg growth 3Y12%
ROICexcg growth 5Y7.99%
ROICexc growth 3Y11.28%
ROICexc growth 5Y7.36%
OM growth 3Y5.47%
OM growth 5Y-2.9%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y2.83%
GM growth 5Y-0.77%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 18.7
Debt/EBITDA 4.81
Cap/Depr 57.16%
Cap/Sales 22.38%
Interest Coverage 2.35
Cash Conversion 65.13%
Profit Quality 192.35%
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 0.48
F-Score6
WACC6.73%
ROIC/WACC0.39
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.5%
EPS 3Y-2.7%
EPS 5Y-2.64%
EPS Q2Q%-92.31%
EPS Next Y-36.83%
EPS Next 2Y-10.92%
EPS Next 3Y-9.72%
EPS Next 5Y-2.84%
Revenue 1Y (TTM)23.82%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%26.07%
Revenue Next Year5.01%
Revenue Next 2Y4.57%
Revenue Next 3Y4.61%
Revenue Next 5Y-29.18%
EBIT growth 1Y30.97%
EBIT growth 3Y18.66%
EBIT growth 5Y13.45%
EBIT Next Year242.43%
EBIT Next 3Y56.29%
EBIT Next 5Y33.61%
FCF growth 1Y122.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.95%
OCF growth 3Y10.42%
OCF growth 5Y4.82%